Pharmacoeconomic impact of use of the probiotic Lactobacillus reuteri DSM 17938 for prevention of necrotizing enterocolitis in extremely low-birth-weight infants

by Dimaguila MAVT, Gal P, Wilson T, Wimmer Jr JE, Smith M, Carlos RQ, Davanzo CC, Ransom JL
Published 2013-04-01